167 related articles for article (PubMed ID: 28688522)
1. Porta hepatis debulking procedures as part of primary cytoreductive surgery for advanced ovarian cancer.
Son JH; Chang SJ; Ryu HS
Gynecol Oncol; 2017 Sep; 146(3):672-673. PubMed ID: 28688522
[No Abstract] [Full Text] [Related]
2. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
[TBL] [Abstract][Full Text] [Related]
3. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
Cordeiro Vidal G; Babin G; Querleu D; Guyon F
Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
[TBL] [Abstract][Full Text] [Related]
4. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
Kim HS; Bristow RE; Chang SJ
Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
[TBL] [Abstract][Full Text] [Related]
5. Step by step right upper quadrant cytoreduction guided by computed tomography in advanced ovarian cancer.
Celik M; Tasci T; Basaran D; Tulunay G
Gynecol Oncol; 2015 Dec; 139(3):582-3. PubMed ID: 26456140
[No Abstract] [Full Text] [Related]
6. Metastatic peripancreatic lymph nodes resection during primary debulking surgery for primary peritoneal serous carcinoma.
Nishikimi K; Tate S; Matsuoka A; Sakai N; Otsuka M; Shozu M
Gynecol Oncol; 2020 May; 157(2):555-557. PubMed ID: 32192733
[TBL] [Abstract][Full Text] [Related]
7. Approach to the Porta Hepatis During Cytoreductive Surgery: Technical Considerations.
Aydin N; Sardi A; Milovanov V
Ann Surg Oncol; 2016 Feb; 23(2):552-5. PubMed ID: 26577121
[TBL] [Abstract][Full Text] [Related]
8. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
Khatib G; Guzel AB; Gulec UK; Vardar MA
Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
[TBL] [Abstract][Full Text] [Related]
9. Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer.
Chen Y; Sun Z; Cai S; Hu Y; Jiang R; Xiang L; Zang R
J Gynecol Oncol; 2024 May; 35(3):e25. PubMed ID: 38130134
[TBL] [Abstract][Full Text] [Related]
10. Kocher maneuver to facilitate cytoreduction within the foramen of Winslow.
Han SS; Sugarbaker PH
J Surg Oncol; 2017 Jun; 115(7):788-790. PubMed ID: 28475818
[TBL] [Abstract][Full Text] [Related]
11. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA
Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261
[TBL] [Abstract][Full Text] [Related]
14. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR
Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
[TBL] [Abstract][Full Text] [Related]
15. Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer.
Son JH; Dong SR; Kim J; Kim J; Kong TW; Chang SJ
BMC Surg; 2023 Mar; 23(1):60. PubMed ID: 36941661
[TBL] [Abstract][Full Text] [Related]
16. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach.
Nougaret S; Addley HC; Colombo PE; Fujii S; Al Sharif SS; Tirumani SH; Jardon K; Sala E; Reinhold C
Radiographics; 2012 Oct; 32(6):1775-800; discussion 1800-3. PubMed ID: 23065169
[TBL] [Abstract][Full Text] [Related]
18. Complete tumor resection and demonstration of detailed anatomy of the porta hepatis in a patient with recurrent epithelial ovarian cancer.
Taskiran C; Vatansever D; Misirlioglu S; Giray B; Kumcular T; Arvas M; Erkan M
Int J Gynecol Cancer; 2021 Jan; 31(1):148-149. PubMed ID: 33303569
[No Abstract] [Full Text] [Related]
19. Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer.
Nasser S; Lathouras K; Nixon K; Campbell J; Stocks G; Jiao L; Fotopoulou C
Gynecol Oncol; 2018 Dec; 151(3):466-470. PubMed ID: 30278996
[TBL] [Abstract][Full Text] [Related]
20. Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer.
Song YJ; Lim MC; Kang S; Seo SS; Kim SH; Han SS; Park SY
Gynecol Oncol; 2011 May; 121(2):253-7. PubMed ID: 21277009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
